Paul Schimmel, Director at aTYR PHARMA INC (LIFE), bought 40,000 shares at $3.19 ($128K) on 2016-04-07, disclosed to the SEC on 2016-04-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ATYR | BUY | 2024-07-24 | $256K | — | Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |